Research Article
Combining the Fibrinogen/Albumin Ratio and Systemic Inflammation Response Index Predicts Survival in Resectable Gastric Cancer
Table 2
The clinicopathological characteristics stratified by the FAR-SIRI score.
| | Characteristics | FAR-SIRI 0 | FAR-SIRI 1 | FAR-SIRI 2 | value | | () | () | () |
| | Sex | | | | | | Male | 74 (47.4) | 29 (18.6) | 53 (34.0) | 0.030 | | Female | 49 (65.3) | 7 (9.3) | 19 (25.3) | | | Age (years) | | | | | | <60 | 48 (63.2) | 10 (13.2) | 18 (23.7) | 0.103 | | ≥60 | 75 (48.4) | 26 (16.8) | 54 (34.8) | | | Tumour location | | | | | | Upper third | 22 (40.7) | 14 (25.9) | 18 (33.3) | 0.010 | | Middle third | 35 (66.0) | 6 (11.3) | 12 (22.6) | | | Lower third | 66 (55.5) | 15 (12.6) | 38 (31.9) | | | Mixed | 0 (0) | 1 (20) | 4 (80) | | | Tumour size (cm) | | | | | | <3 | 64 (74.4) | 11 (12.8) | 11 (12.8) | <0.001 | | ≥3 | 59 (40.7) | 25 (17.2) | 61 (42.1) | | | T stage | | | | | | 1 | 45 (95.7) | 1 (2.1) | 1 (2.1) | <0.001 | | 2 | 20 (64.5) | 6 (19.4) | 5 (16.1) | | | 3 | 31 (42.5) | 13 (17.8) | 29 (39.7) | | | 4 | 27 (33.8) | 16 (20.0) | 37 (46.3) | | | N stage | | | | | | 1 | 64 (78.1) | 8 (9.8) | 10 (12.2) | <0.001 | | 2 | 23 (46.9) | 13 (26.5) | 13 (26.5) | | | 3 | 20 (30.8) | 10 (15.4) | 35 (53.9) | | | Differentiation | | | | | | Poor | 95 (49.0) | 35 (18.0) | 64 (33.0) | 0.006 | | Moderate and well | 28 (75.7) | 1 (2.7) | 8 (21.6) | | | TNM stage | | | | | | I | 54 (91.5) | 4 (6.8) | 1 (1.7) | <0.001 | | II | 35 (53.9) | 11 (16.9) | 19 (29.2) | | | III | 34 (31.8) | 21 (19.6) | 52 (48.6) | |
|
|
Fisher’s exact test; others, chi-square test. |
